Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Pre-Clinical Evaluation of a Camsirubicin Analog Mnpr-202 in Diffuse Large B Cell Lymphoma

Julie A.S. Lammers, Hoang Mai Phuong, Charmaine Ong, Min Liu, Patrick Jaynes, Raji R. Nair, Wee Joo Chng, Chandler D. Robinson, Anand D. Jeyasekharan

Blood (2022) 140 (Supplement 1): 5998–5999.

https://doi.org/10.1182/blood-2022-168761

Published: 2022

Journal Articles

Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody

Ariel F Grajales-Cruz, MD, Julio Chavez, Virginia Olivia Volpe, MD, Jose Sandoval-Sus, MD, Bijal Shah, MD, Celeste Bello, MD, Lubomir Sokol, MD PhD, Shanel Fisher, Rajesh R Nair, PhD, Yun Seongseok, MD, Hayder Saeed, MD, Leidy Isenalumhe, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Javier Pinilla Ibarz, MD PhD

Blood (2019) 134 (Supplement_1): 5484.

https://doi.org/10.1182/blood-2019-129260

Published: 2019

Journal Articles

In Situ CD28-CD86 Interactions on Myeloma - Targeting the Achilles Heel

Jayakumar R. Nair, PhDMSc,BSc, Louise Carlson, BS, Kelvin P. Lee, MD

Blood (2015) 126 (23): 4184.

https://doi.org/10.1182/blood.V126.23.4184.4184

Published: 2015

Journal Articles

Predicting Non-Responders to Immunotherapy Treatments through Simulation of NGS Information

Kim A. Brogden, Carol L. Fischer, Amber M. Bates, Emily A. Lanzel, Maria Paula Gomez Hernandez, Christopher N. Treinen, Erica N. Recker, Prashant R. Nair, Karthik Sundara, Vishwas Joseph, Taher Abbasi, Shireen Vali

Blood (2015) 126 (23): 1803.

https://doi.org/10.1182/blood.V126.23.1803.1803

Published: 2015

Journal Articles

Targeting the Serine-Threonine Kinase PIM2: Implications in IL-6 Mediated Survival in Myeloma

Jayakumar R Nair, PhD, Tyger L Howell, BS, Justin Caserta, MBA,BS, Carmen M Baldino, PhD, Gerald Fetterly, PhD, Kelvin P Lee, MD

Blood (2014) 124 (21): 3401.

https://doi.org/10.1182/blood.V124.21.3401.3401

Published: 2014

Journal Articles

A Novel Method of Using Molecular Profiling in Myelodysplastic Syndromes to Predict Patient-Specific Potential Therapeutics

Christopher R. Cogle, MD, Gaurav Trikha, MBBS, MD, Peter P. Sayeski, PhD, Shireen Vali, PhD, Ansu Kumar, Neeraj Kumar Singh, Prashant R Nair, Deepak Anil Lala, Kabya Basu, Taher Abbasi, MS, Maher Albitar, MD

Blood (2014) 124 (21): 5591.

https://doi.org/10.1182/blood.V124.21.5591.5591

Published: 2014

Journal Articles

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Megan E. Murray, Catherine M. Gavile, Jayakumar R. Nair, Chandana Koorella, Louise M. Carlson, Daniela Buac, Adam Utley, Marta Chesi, P. Leif Bergsagel, Lawrence H. Boise, Kelvin P. Lee

Blood (2014) 123 (24): 3770–3779.

https://doi.org/10.1182/blood-2013-10-530964

Published: 2014

Includes: Supplemental data

Journal Articles

Overcoming CD28-Mediated Multi-Drug Resistance With a Novel PIM2 Inhibitor

Carmen M. Baldino, Ph.D., Jayakumar R. Nair, Ph.D., Justin Caserta, B.S., M.B.A, Megan Murray, Ph.D, Stephane Dumas, Yvonne Flanders, Kelvin P. Lee, MD

Blood (2013) 122 (21): 1931.

https://doi.org/10.1182/blood.V122.21.1931.1931

Published: 2013

Journal Articles

CD28 Regulates Metabolism In Multiple Myeloma For Cell Survival and Proliferation

Adam T Utley, BS, BA, Megan Murray, Ph.D, Louise M Carlson, BS, Matthew R. Farren, B.S., Jayakumar R Nair, Ph.D., Kelvin P Lee, MD

Blood (2013) 122 (21): 5400.

https://doi.org/10.1182/blood.V122.21.5400.5400

Published: 2013

Journal Articles

Reversing Drug Resistance and CD28 Mediated Survival In Myeloma Via The Novel Redox Regulator Thioredoxin

Jayakumar R Nair, Ph.D., Louise M Carlson, BS, Kelvin P Lee, MD

Blood (2013) 122 (21): 756.

https://doi.org/10.1182/blood.V122.21.756.756

Published: 2013

Journal Articles

Mti-101 (cyclized HYD1) Binds to CD44 and Induces Necrotic Cell Death in Multiple Myeloma

Anthony W. Gebhard, M.S., Rajesh R Nair, Ph.D., Michael Emmons, Ph.D, Priyesh R Jain, Ph.D., Andreas Becker, Ph.D., John Koomen, Ph.D., Ernst Schonbrunn, Ph.D., Daniel M Sullivan, MD, Mark L McLaughlin, Ph.D., Lori A Hazlehurst, Ph.D

Blood (2012) 120 (21): 4022.

https://doi.org/10.1182/blood.V120.21.4022.4022

Published: 2012

Journal Articles

CD28 and CD86 Are Necessary for Myeloma Cell Survival.

Catherine M Gavile, BS, Jayakumar R Nair, Ph.D., Kelvin P Lee, MD, Sagar Lonial, MD, Lawrence H. Boise, PhD

Blood (2012) 120 (21): 2946.

https://doi.org/10.1182/blood.V120.21.2946.2946

Published: 2012

Journal Articles

Targeting the Cellular and Molecular Components of CD28 Mediated Survival Signaling in Multiple Myeloma

Jayakumar R Nair, Ph.D., Megan Murray, Chandana Koorella, Louise M Carlson, Lawrence H. Boise, PhD, Kelvin P Lee, MD

Blood (2012) 120 (21): 722.

https://doi.org/10.1182/blood.V120.21.722.722

Published: 2012

Journal Articles

CD28-Mediated Pro-Survival Signaling in Multiple Myeloma

Megan E Murray, Jayakumar R Nair, Ph.D., Kelvin P Lee, MD

Blood (2012) 120 (21): 941.

https://doi.org/10.1182/blood.V120.21.941.941

Published: 2012

Journal Articles

Mti-101 Induces Necrotic Cell Death in AML Cells Through Its Binding to Cell Surface Complexes Containing CD44 and ITGA4

Rajesh R Nair, Ph.D., Joel H Tolentino, PhD, Milijana Ugrenovic, BSc, Priyesh R Jain, Ph.D., Mark L McLaughlin, Ph.D., Jeffrey E Lancet, MD, Lori A Hazlehurst, Ph.D

Blood (2012) 120 (21): 869.

https://doi.org/10.1182/blood.V120.21.869.869

Published: 2012

Journal Articles

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Sudha Mannava, DaZhong Zhuang, Jayakumar R. Nair, Rajat Bansal, Joseph A. Wawrzyniak, Shoshanna N. Zucker, Emily E. Fink, Kalyana C. Moparthy, Qiang Hu, Song Liu, Lawrence H. Boise, Kelvin P. Lee, Mikhail A. Nikiforov

Blood (2012) 119 (6): 1450–1458.

https://doi.org/10.1182/blood-2011-04-346676

Published: 2012

Includes: Supplemental data

Journal Articles

Sustained Antibody Responses Depend on CD28 Function in Bone Marrow Resident Plasma Cells

Cheryl H Rozanski, BS, Lindzy F Dodson, PhD, Ramon Arens, PhD, Louise M Carlson, Lisa M Russell, PhD, Jayakumar R Nair, Ph.D., Asher Chanan-Khan, Lee Ann Garrett-Sinha, PhD, Jonathan M Green, MD, Stephen P Schoenberger, PhD, Lawrence H. Boise, PhD, Kelvin P Lee, MD

Blood (2011) 118 (21): 182.

https://doi.org/10.1182/blood.V118.21.182.182

Published: 2011

Journal Articles

CD28-Mediated Pro-Survival Signaling in Multiple Myeloma

Megan E Murray, Jayakumar R Nair, Ph.D., Kelvin P. Lee, MD

Blood (2011) 118 (21): 2921.

https://doi.org/10.1182/blood.V118.21.2921.2921

Published: 2011

Journal Articles

Crosstalk Between Notch and CD80/86 Signaling In Multiple Myeloma

Chandana Koorella, Jayakumar R Nair, Ph.D., Louise M Carlson, Kelvin P. Lee, MD

Blood (2011) 118 (21): 1111.

https://doi.org/10.1182/blood.V118.21.1111.1111

Published: 2011

Journal Articles

Prosurvival and Immunosuppressive Functions of CD28 in the Myeloma Tumor Microenvironment

Jayakumar R Nair, Ph.D., Megan Murray, Chandana Koorella, Cheryl H Rozanski, BS, Louise M Carlson, Lawrence H. Boise, PhD, Kelvin P Lee, MD

Blood (2011) 118 (21): 473.

https://doi.org/10.1182/blood.V118.21.473.473

Published: 2011

NARROW

Pre-Clinical Evaluation of a Camsirubicin Analog Mnpr-202 in Diffuse Large B Cell Lymphoma

Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody

In Situ CD28-CD86 Interactions on Myeloma - Targeting the Achilles Heel

Predicting Non-Responders to Immunotherapy Treatments through Simulation of NGS Information

Targeting the Serine-Threonine Kinase PIM2: Implications in IL-6 Mediated Survival in Myeloma

A Novel Method of Using Molecular Profiling in Myelodysplastic Syndromes to Predict Patient-Specific Potential Therapeutics

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Overcoming CD28-Mediated Multi-Drug Resistance With a Novel PIM2 Inhibitor

CD28 Regulates Metabolism In Multiple Myeloma For Cell Survival and Proliferation

Reversing Drug Resistance and CD28 Mediated Survival In Myeloma Via The Novel Redox Regulator Thioredoxin

Mti-101 (cyclized HYD1) Binds to CD44 and Induces Necrotic Cell Death in Multiple Myeloma

CD28 and CD86 Are Necessary for Myeloma Cell Survival.

Targeting the Cellular and Molecular Components of CD28 Mediated Survival Signaling in Multiple Myeloma

CD28-Mediated Pro-Survival Signaling in Multiple Myeloma

Mti-101 Induces Necrotic Cell Death in AML Cells Through Its Binding to Cell Surface Complexes Containing CD44 and ITGA4

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Sustained Antibody Responses Depend on CD28 Function in Bone Marrow Resident Plasma Cells

CD28-Mediated Pro-Survival Signaling in Multiple Myeloma

Crosstalk Between Notch and CD80/86 Signaling In Multiple Myeloma

Prosurvival and Immunosuppressive Functions of CD28 in the Myeloma Tumor Microenvironment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only